Triple negative breast cancer in the era of miRNA-Reference-Cited by-同舟云学术

Triple negative breast cancer in the era of miRNA

Published:2021-01 Issue: Volume:157 Page:103196
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Sabit Hussein,Cevik Emre^ORCID,Tombuloglu Huseyin,Abdel-Ghany Shaimaa,Tombuloglu Guzin,Esteller Manel

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference195 articles.

1. MiR-34a silences c-SRC to attenuate tumor growth in triple-negative breast cancer;Adams;Cancer Res.,2016

2. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells;Ahmad;Mol. Cancer Ther.,2012

3. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer;Andorfer;Trends Mol. Med.,2011

4. MiR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer;Augoff;Mol. Cancer,2012

5. Genome-wide miRNA, gene and methylation analysis of triple negative breast cancer to identify changes associated with lymph node metastases;Avery-Kiejda;Genom. Data,2017

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer;International Journal of Biological Macromolecules;2024-08

2. Expression and function of cytokine interleukin-22 gene in the tumor microenvironment of triple negative breast cancer;Cytokine;2024-07

3. Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA–mRNA network and signature analysis;Scientific Reports;2024-02-29

4. MXene-Based Nanocomposite-Facilitated Photothermal Therapy by Preventing Expression of Heat Shock Protein 90;International Journal of Nanoscience;2024-01-10

5. Extracellular vesicles-associated miRNAs in triple-negative breast cancer: from tumor biology to clinical relevance;Life Sciences;2024-01